These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38463146)

  • 1. Clinicopathological Aspects and Inflammation-Immune Markers in Alcohol and/or Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients Treated With Sorafenib.
    Pinto TAM; Saito HPA; Nourani CL; Ataide EC; Boin IFSF; Lourenco GJ; Lima CSP
    Gastroenterology Res; 2024 Feb; 17(1):23-31. PubMed ID: 38463146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors.
    Huang R; Zheng Y; Zou W; Liu C; Liu J; Yue J
    J Immunol Res; 2022; 2022():3781109. PubMed ID: 36033384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation-Based Prognostic Scores in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Transplantation.
    Ren A; Li Z; Zhang X; Deng R; Ma Y
    J Hepatocell Carcinoma; 2020; 7():101-106. PubMed ID: 32766175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic immune-inflammation index predicts prognosis of sequential therapy with sorafenib and regorafenib in hepatocellular carcinoma.
    Hong YM; Yoon KT; Cho M
    BMC Cancer; 2021 May; 21(1):569. PubMed ID: 34006248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of systemic immune-inflammation index in patients with bone metastases from hepatocellular carcinoma treated with radiotherapy.
    Chen J; Huang W; Xu X; Fan S; Zhang Q; Li X; Zeng Z; He J
    Front Oncol; 2023; 13():1076428. PubMed ID: 37251953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of platelet-to-lymphocyte and neutrophil-to-lymphocyte ratio in HCC treated with sorafenib and radioembolization.
    Öcal O; Kimm MA; Hoang TPT; Pech M; Öcal E; Ben Khaled N; Sangro B; Ricke J; Seidensticker M; Wildgruber M
    JHEP Rep; 2024 Apr; 6(4):100995. PubMed ID: 38440069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
    Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies.
    Bruix J; Cheng AL; Meinhardt G; Nakajima K; De Sanctis Y; Llovet J
    J Hepatol; 2017 Nov; 67(5):999-1008. PubMed ID: 28687477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Systemic Inflammation Response Index with Short-Term Functional Outcome in Patients with Acute Ischemic Stroke.
    Zhang YX; Shen ZY; Jia YC; Guo X; Guo XS; Xing Y; Tian SJ
    J Inflamm Res; 2023; 16():3619-3630. PubMed ID: 37641703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era.
    Li Q; Yu L; Yang P; Hu Q
    Cancer Manag Res; 2021; 13():6799-6810. PubMed ID: 34512020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy.
    Zheng C; Ye S; Liu W; Diao M; Li L
    Front Oncol; 2023; 13():1276175. PubMed ID: 37901310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Inflammatory and Nutritional Markers for Patients With Early-Stage Poorly-to Moderately-Differentiated Cervical Squamous Cell Carcinoma.
    Guo J; Lv W; Wang Z; Shang Y; Yang F; Zhang X; Xiao K; Zhang S; Pan X; Han Y; Zong L; Hu W
    Cancer Control; 2023; 30():10732748221148913. PubMed ID: 36599103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation.
    Ali MAM; Harmsen WS; Morsy KH; Galal GMK; Therneau TM; Roberts LR
    BMC Cancer; 2022 Feb; 22(1):221. PubMed ID: 35227234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells.
    Zhao M; Duan X; Han X; Wang J; Han G; Mi L; Shi J; Li N; Yin X; Hou J; Yin F
    Front Oncol; 2022; 12():854096. PubMed ID: 35463384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors.
    Cao J; Chen Q; Bai X; Liu L; Ma W; Lin C; Lu F; Zhou T; Zhan J; Huang Y; Yang Y; Luo F; Zhao H
    Ann Med; 2023; 55(2):2280002. PubMed ID: 38065623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-secretion of AFP and neutrophil lymphocyte ratio as predictors for survival in hepatocellular carcinoma patients treated with sorafenib: a large UK cohort.
    Afshar M; Fletcher P; Bardoli AD; Ma YT; Punia P
    Oncotarget; 2018 Mar; 9(24):16988-16995. PubMed ID: 29682199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of preoperative inflammatory indexes for postoperative early recurrence of hepatitis B-related hepatocellular carcinoma.
    Wenpei G; Yuan L; Liangbo L; Jingjun M; Bo W; Zhiqiang N; Yijie N; Lixin L
    Front Oncol; 2023; 13():1142168. PubMed ID: 37519805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments.
    Zhao LY; Yang DD; Ma XK; Liu MM; Wu DH; Zhang XP; Ruan DY; Lin JX; Wen JY; Chen J; Lin Q; Dong M; Qi JJ; Hu PS; Zeng ZL; Chen ZH; Wu XY
    J Cancer; 2019; 10(10):2299-2311. PubMed ID: 31258733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.